Selective N-pyrimidinyl pyrroloquinolone PDE5 inhibitors as agents for treatment of male erectile dysfunction.

被引：0

作者：

Jiang, WQ ^{[1
]}

Sui, ZH ^{[1
]}

Guan, JH ^{[1
]}

Macielag, MJ ^{[1
]}

Zhang, SY ^{[1
]}

Qiu, YH ^{[1
]}

Kraft, P ^{[1
]}

Bhattacharjee, S ^{[1
]}

Lombardi, E ^{[1
]}

Haynes-Johnson, D ^{[1
]}

John, TM ^{[1
]}

Clancy, J ^{[1
]}

机构：

[1] Johnson & Johnson PRD, Drug Discovery, Raritan, NJ 08869 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

282-MEDI

引用

页码：U56 / U56

页数：1

共 50 条

[1] Furoyl pyrroloquinolones as selective PDE5 inhibitors for treatment of male erectile dysfunction.
Jiang, WQ
Sui, ZH
Guan, JH
Macielag, MJ
Walsh, SP
Lanter, JC
Fiordeliso, JJ
Qiu, YH
Kraft, P
Bhattacharjee, S
Haynes-Johnson, D
Lombardi, E
John, TM
Clancy, J
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U56
[2] B-carboline as PDE5 inhibitors for treatment of male erectile dysfunction.
Guan, JH
Jiang, WQ
Sui, ZH
Macielag, MJ
Walsh, SP
Lanter, JC
Fiordeliso, JJ
Alford, VC
Qiu, YH
Patricia, K
Bhattacharjee, S
Lombardi, E
Haynes-Johnson, D
John, TM
Clancy, J
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U55
[3] Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction
Jiang, WQ
Guan, JH
Macielag, MJ
Zhang, SY
Qiu, YH
Kraft, P
Bhattacharjee, S
John, TM
Haynes-Johnson, D
Lundeen, S
Sui, ZH
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2126 - 2133
[4] Pyrazolopyrimidinone Based Selective Inhibitors of PDE5 for the Treatment of Erectile Dysfunction
Hudwekar, Abhinandan D.
Kotwal, Pankul
Dar, Mohd. Ishaq
Balgotra, Shilpi
Dogra, Ashish
Kour, Jaspreet
Chobe, Santosh S.
Nandi, Utpal
Hussain Syed, Sajad
Sawant, Sanghapal D.
[J]. CHEMISTRY & BIODIVERSITY, 2023, 20 (04)
[5] Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
Bi, YZ
Stoy, P
Adam, L
He, B
Krupinski, J
Normandin, D
Pongrac, R
Seliger, L
Watson, A
Macor, JE
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1577 - 1580
[6] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
Yu, GX
Mason, HJ
Wu, XM
Wang, J
Chong, SH
Dorough, G
Henwood, A
Pongrac, R
Seliger, L
He, B
Normandin, D
Adam, L
Krupinski, J
Macor, JE
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1025 - 1027
[7] PDE5 Inhibitors for Erectile Dysfunction
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1383): : 10 - 11
[8] N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
Rotella, DP
Sun, Z
Zhu, YH
Krupinski, J
Pongrac, R
Seliger, L
Normandin, D
Macor, JE
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) : 1257 - 1263
[9] Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction
Sui, ZH
Guan, JH
Macielag, MJ
Jiang, WQ
Zhang, SY
Qiu, YH
Kraft, P
Bhattacharjee, S
John, TM
Haynes-Johnson, D
Clancy, J
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) : 4094 - 4096
[10] Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
Yu, GX
Mason, H
Wu, XM
Wang, J
Chong, SH
Beyer, B
Henwood, A
Pongrac, R
Seliger, L
He, B
Normandin, D
Ferrer, P
Zhang, RG
Adam, L
Humphrey, WG
Krupinski, J
Macor, JE
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) : 457 - 460

← 1 2 3 4 5 →